Bambuterol


Concise Prescribing Info
Indications/Uses
Persistent reversible airways obstruction.
Dosage/Direction for Use
Adult: PO 10-20 mg/day at bedtime.
Special Precautions
Patient w/ liver cirrhosis and other causes of severely impaired liver function; underlying severe heart disease (e.g. ischaemic heart disease, arrhythmia or severe heart failure); thyrotoxicosis, DM, hypertrophic cardiomyopathy, predisposition to angle closure glaucoma. Not intended for relief of acute bronchospasm or in patients w/ unstable resp disease. Moderate to severe renal impairment. Pregnancy and lactation.
Adverse Reactions
Behavioural disturbances (e.g. restlessness, agitation), tremor, headache, sleep disturbances, palpitations, muscle cramps, hypersensitivity reactions, hypokalaemia, hyperglycaemia, dizziness, hyperactivity, tachycardia, cardiac arrhythmias, myocardial ischaemia, paradoxical bronchospasm, nausea.
Drug Interactions
Prolonged muscle-relaxing effect of other sympathomimetics (e.g. suxamethonium). Increased risk of hypokalaemia by co-admin w/ corticosteroids, diuretics or xanthine derivatives. Partial or total inhibition of effects w/ non-selective β-blockers.
ATC Classification
R03CC12 - bambuterol ; Belongs to the class of adrenergics for systemic use, selective beta-2-adrenoreceptor agonists. Used in the treatment of obstructive airway diseases.
Disclaimer: This information is independently developed by CIMS based on bambuterol from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in